Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × aldesleukin × 1 year × Clear all

Sponsor

Conditions

Melanoma 14 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Ovarian Neoplasms 8 Stomach Neoplasms 7 Leukemia, Myeloid, Acute 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Skin Neoplasms 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Neuroblastoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Hematologic Neoplasms 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Vulvar Neoplasms 2 Urogenital Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid 2

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡